Resources, Production Scales and Time Required for Producing RNA Vaccines for the Global Pandemic Demand
To overcome pandemics, such as COVID-19, vaccines are urgently needed at very high volumes. Here we assess the techno-economic feasibility of producing RNA vaccines for the demand associated with a global vaccination campaign. Production process performance is assessed for three messenger RNA (mRNA)...
Auteurs principaux: | Zoltán Kis, Cleo Kontoravdi, Robin Shattock, Nilay Shah |
---|---|
Format: | Article |
Langue: | English |
Publié: |
MDPI AG
2020-12-01
|
Collection: | Vaccines |
Sujets: | |
Accès en ligne: | https://www.mdpi.com/2076-393X/9/1/3 |
Documents similaires
-
A self-amplifying RNA vaccine provides protection in a murine model of bubonic plague
par: Robin John Shattock, et autres
Publié: (2023-11-01) -
Vaccines’ New Era-RNA Vaccine
par: Wenshuo Zhou, et autres
Publié: (2023-08-01) -
Advancing mRNA technologies for therapies and vaccines: An African context
par: Dylan Kairuz, et autres
Publié: (2022-10-01) -
The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview
par: Bruna Aparecida Souza Machado, et autres
Publié: (2021-11-01) -
Evaluation of a self-amplifying mRNA reporter vaccine in explant models of broiler chickens
par: Janne Snoeck, et autres
Publié: (2023-11-01)